Peter O'Donnell to Nectins
This is a "connection" page, showing publications Peter O'Donnell has written about Nectins.
Connection Strength
0.412
-
In Reply. Oncologist. 2022 10 01; 27(10):e827-e828.
Score: 0.188
-
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin. Oncologist. 2022 03 11; 27(3):e223-e232.
Score: 0.181
-
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2021 06; 22(6):872-882.
Score: 0.043